Cicatricial pemphigoid: a re-evaluation of therapy

References

• de Carvalho C R, Amato M B, Da Suva L M, et al. Obstructive respiratory failure in cicatricial pemphigoid. Thorax 1989; 44(7)601–2
   Google Scholar
• Drenger B, Zidenbaum M, Reifen E, et al. Severe upper airway obstruction and difficult intubation in CP. Anaesthesia 1986; 41(10)1029–31
   Google Scholar
• Payen J L, Pienkowski P, Suduca J M, et al. Cicatricial pemphigoid. A rare cause of esophageal stenosis. Gastroenterol Clin Biol. 1989; 13(11)948–9, letter
   Google Scholar
• Lever W F. Pemphigus and pemphigoid: a review of the advances made since 1964. J Am Acad Dermatol 1979; 1: 2–31
   PubMed Web of Science ®Google Scholar
• Person J R, Rogers R S, III. Bullous and cicatricial pemphigoid. Clinical, histological and immunopathologic correlations. Mayo Clin Proc 1977; 52: 54–66
   PubMed Web of Science ®Google Scholar
• Ahmed A R, Kurgis B S, Rogers R S, III. Cicatricial pemphigoid. J Am Acad Dermatol 1991; 24: 978–1001
   Google Scholar
• Anhalt G J. Pemphigoid: Bullous and cicatricial. Dermatol Clin 1990; 8(4)701–16
   Google Scholar
• Siegel M A, Balciunas B A, Kelly M, et al. Diagnosis and management of commonly occurring oral vesiculoerosive disorders. Cutis 1991; 47: 39–43
   Google Scholar
• Lozada F, Silverman S, Jr. Topically applied fluocinonide in an adhesive base in the treatment of oral vesiculoerosive diseases. Arch Dermatol 1980; 116: 898–901
   Google Scholar
• Lozada-Nur F, Huang M Z, Zhou G A. Open preliminary clinical trial of clobetasol propionate ointment in adhesive base for treatment of chronic oral vesiculoerosive diseases. Oral Surg Oral Med Oral Pathol 1991; 71: 283–7
   PubMedGoogle Scholar
• Ahmed A R, Hombal S H. Cicatricial pemphigoid. Int J Dermatol 1986; 25: 90–6
   PubMed Web of Science ®Google Scholar
• Urbannck V E, Cohen L. Benign mucous membrane pemphigoid: management of an edentulous patient. Oral Surg 1971; 31(6)772–6
   Google Scholar
• Rogers R S, III, Seehafer J R, Perry H O. Treatment of cicatricial (benign mucous membrane) pemphigoid with dapsone. J Am Acad Dermatol 1982; 6: 215–23
   PubMed Web of Science ®Google Scholar
• Bean S F. Diagnosis and management of chronic oral mucosal bullous diseases. Dermatol Clin 1987; 5(4)751–60
   Google Scholar
• Vaillant L, Arbielle B, Gaga D, et al. Cicatricial pemphigoid disclosed by superficial desquamative gingivitis. Clinical and immunoelectron microscopic study of a case. Ann Dermatol Venereol 1990; 117(9)613–20
   Google Scholar
• Rogers R S, III, Sheridan P J, Nightingale S H. Desquamative gingivitis: Clinical, histopathologic, immunopathologic, and therapeutic observations. J Am Acad Dermatol 1982; 7: 729–35
   Google Scholar
• Rogers R S, III. Dapsone and sulfapyridine therapy of pemphigoid diseases. Australas J Dermatol 1986; 27(2)58–63
   Google Scholar
• McFadden J P, Leonard J N, Powles A V, et al. Sulphameth-oxypyridazine for dermatitis herpetiformis, linear IgA disease and cicatricial pemphigoid. Br J Dermatol 1989; 121: 759–62
   PubMed Web of Science ®Google Scholar
• Michel B, Bean S F, Chorzelski T, et al. Cicatricial pemphigoid of Brunsting Perry. Immunofluorescent studies. Arch Dermatol 1977; 113: 1403–5
   Google Scholar
• Bernstein J E, Lorincz A L. Sulfonamides and sulfones in dermatologic therapy—review. Int J Dermatol 1981; 20: 81–8
   PubMedGoogle Scholar
• Booth S A, Moody C E, Dahl M V, et al. Dapsone suppresses integrin-mediated neutrophil adherence function. J Invest Dermatol 1992; 98: 135–40
   PubMed Web of Science ®Google Scholar
• Roenigk H H, Deodhar S. Pemphigus treated with azathioprine. Clinical and immunologic correlation. Arch Dermatol 1973; 107: 353–7
   PubMedGoogle Scholar
• Dantzig P I. Circulating antibodies in cicatricial pemphigoid. Arch Dermatol 1973; 108: 264–6
   PubMed Web of Science ®Google Scholar
• Dave V K, Vickers C FH. Azathioprine in the treatment of mucocutaneous pemphigoid. Br J Dermatol 1974; 90: 183–6
   PubMed Web of Science ®Google Scholar
• Mondino B J, Stuart I B. Immunosuppressive therapy in ocular CP. Am J Ophthalmol 1983; 96: 453–9
   PubMed Web of Science ®Google Scholar
• Brody H J, Pirozzi D J. Benign mucous membrane pemphigoid. Response to therapy with cyclophosphamide. Arch Dermatol 1977; 113: 1598–9
   PubMedGoogle Scholar
• Foster C S, Wilson L A, Ekins M B. Immunosuppressive therapy for progressive ocular cicatricial pemphigoid. Ophthalmology 1982; 89: 340–53
   PubMed Web of Science ®Google Scholar
• Tauber J, Sainz-de-la-Maza M, Foster C S. Systemic chemotherapy for ocular cicatricial pemphigoid. Cornea 1991; 10(3)185–95
   Google Scholar
• Rapini R P. Cytotoxic drugs in the treatment of skin disease. Int J Dermatol 1991; 30: 313–22
   Google Scholar
• Berk M A, Lorincz A L. The treatment of bullous pemphigoid with tetracycline and niacinamide. Arch Dermatol 1986; 122: 670–4
   PubMed Web of Science ®Google Scholar
• Peoples D, Fivenson D P. Linear IgA bullous dermatosis: successful treatment with tetracycline and nicotinamide. J Am Acad Dermatol 1992; 26: 498–9
   PubMed Web of Science ®Google Scholar
• Ronbeck B A, Lind P O, Thrane P S. Desquamative gingivitis: preliminary observations with tetracycline treatment. Oral Surg Oral Med Oral Pathol 1990; 69: 694–7
   PubMedGoogle Scholar
• Humbert P, Treffel P, Chapuis J F, et al. The tetracyclines in dermatology. J Am Acad Dermatol 1991; 25: 691–7
   PubMed Web of Science ®Google Scholar
• White J E. Minocycline for dystrophic epidermolysis bullosa. Lancet 1989; Vol 1: 966
   Google Scholar
• Argenyl Z B, Finelli L, Bergfeld W F, et al. Minocycline related cutaneous hyperpigmentation as demonstrated by light microscopy, electron microscopy and x-ray electron spectroscopy. J Cutan Pathol 1987; 14: 176–80
   Google Scholar
• Eisen D, Ellis C N, Voorhees J J. Topical cyclosporine for oral bullous disorders. J Am Acad Dermatol 1990; 23: 936–7
   PubMed Web of Science ®Google Scholar
• Bergstrom L. Cicatricial pemphigoid of upper digestive and respiratory tracts. Clin Dermatol 1987; 5(1)36–42
   Google Scholar
• Hansen R D, Olsen K D, Rogers R S, III. Upper aerodigestive tract manifestations of cicatricial pemphigoid. Ann Otol Rhinol Laryngol 1988; 97(5 Pt 1)493–9
   Google Scholar
• Ho H, Suzuki K, Hoshino T, et al. Total laryngeal stenosis in cicatricial pemphigoid. Auris Nasus Larynx 1991; 18(2)163–7
   Google Scholar
• Muller L C, Salzer G M. Stenosis of left mainstream bronchus in a case of cicatricial pemphigoid. Eur J Cardiothorac Surg 1988; 2(4)284–6
   Google Scholar
• Mondino B J, Linstone F A. Ocular pemphigoid. Clin Dermatol 1987; 5(1)28–35
   Google Scholar
• Sainz-de-Ia-Maza M, Tauber J, Foster C S. Cataract surgery in ocular CP. Ophthalmology 1988; 95(4)481–6
   Google Scholar
• Vandeveer M R. Ocular cicatricial pemphigoid. J Am Optom Assoc 1991; 62(3)166–9
   Google Scholar
• Shore J W, Foster C S, Westfall C T, et al. Results of buccal mucosal, grafting for patients with medically controlled ocular cicatricial pemphigoid. Ophthalmology 1992; 99(3)383–95
   Google Scholar
• Wolverton S E. Monitoring for adverse effects from systemic drugs used in dermatology. J Am Acad Dermatol 1992; 26: 661–79
   Google Scholar